View Cart  

CHMP Follows FDA’s Lead, Recommends Four New Drugs for Approval

A A
The EU’s Committee for Medicinal Products for Human Use (CHMP) is recommending approval of four new drugs, including Regeneron’s Eylea for wet age-related macular degeneration (AMD).

To View This Article:

Login

Subscribe To Drug Industry Daily